DRUGS similar to the arthritis drug Vioxx, which has been withdrawn because of a possible risk of heart attack and stroke, are to be reviewed by the European Agency for the Evaluation of Medicinal Products (EMEA) on Monday.

A new impotence drug is set to be launched in the first half of next year after receiving backing from the European body responsible for drug approval, it was announced today.